NO20034972D0 - Behandling av ADHD - Google Patents

Behandling av ADHD

Info

Publication number
NO20034972D0
NO20034972D0 NO20034972A NO20034972A NO20034972D0 NO 20034972 D0 NO20034972 D0 NO 20034972D0 NO 20034972 A NO20034972 A NO 20034972A NO 20034972 A NO20034972 A NO 20034972A NO 20034972 D0 NO20034972 D0 NO 20034972D0
Authority
NO
Norway
Prior art keywords
adhd
treatment
Prior art date
Application number
NO20034972A
Other languages
English (en)
Other versions
NO20034972L (no
Inventor
Klaus Peter Hertel
Joern Arnt
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20034972L publication Critical patent/NO20034972L/no
Publication of NO20034972D0 publication Critical patent/NO20034972D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Recrystallisation Techniques (AREA)
  • Indole Compounds (AREA)
NO20034972A 2001-05-09 2003-11-07 Behandling av ADHD NO20034972D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100732 2001-05-09
PCT/DK2002/000298 WO2002089797A1 (en) 2001-05-09 2002-05-07 Treatment of adhd

Publications (2)

Publication Number Publication Date
NO20034972L NO20034972L (no) 2003-11-07
NO20034972D0 true NO20034972D0 (no) 2003-11-07

Family

ID=8160484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034972A NO20034972D0 (no) 2001-05-09 2003-11-07 Behandling av ADHD

Country Status (23)

Country Link
US (1) US7294638B2 (no)
EP (1) EP1387682A1 (no)
JP (1) JP2004528361A (no)
KR (1) KR20040007544A (no)
CN (1) CN1507351A (no)
AR (1) AR033287A1 (no)
BG (1) BG108400A (no)
BR (1) BR0209443A (no)
CA (1) CA2446652A1 (no)
CO (1) CO5540378A2 (no)
CZ (1) CZ20033197A3 (no)
EA (1) EA200301221A1 (no)
HR (1) HRP20030852A2 (no)
HU (1) HUP0400075A2 (no)
IL (1) IL158413A0 (no)
IS (1) IS6992A (no)
MX (1) MXPA03010136A (no)
NO (1) NO20034972D0 (no)
NZ (1) NZ528896A (no)
PL (1) PL367778A1 (no)
SK (1) SK15002003A3 (no)
WO (1) WO2002089797A1 (no)
ZA (1) ZA200307955B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003102097A1 (en) * 2002-05-31 2003-12-11 H. Lundbeck A/S The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole
EP1812390A2 (en) * 2004-10-22 2007-08-01 Mark Froimowitz Methylphenidate analogs and methods of use thereof
WO2009136410A2 (en) 2008-04-19 2009-11-12 Nisarga Biotech Pvt. Ltd. Herbal composition for reducing add/adhd and method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521197A (en) 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
US6656953B2 (en) * 2000-12-06 2003-12-02 Sepracor Inc. 4,4-Disubstituted piperidines, and methods of use thereof

Also Published As

Publication number Publication date
EA200301221A1 (ru) 2004-04-29
US7294638B2 (en) 2007-11-13
AR033287A1 (es) 2003-12-10
PL367778A1 (en) 2005-03-07
HUP0400075A2 (hu) 2004-04-28
NO20034972L (no) 2003-11-07
CZ20033197A3 (en) 2004-06-16
EP1387682A1 (en) 2004-02-11
CN1507351A (zh) 2004-06-23
MXPA03010136A (es) 2004-03-10
BR0209443A (pt) 2004-08-03
WO2002089797A8 (en) 2004-03-25
JP2004528361A (ja) 2004-09-16
BG108400A (bg) 2004-11-30
IS6992A (is) 2003-10-13
NZ528896A (en) 2004-12-24
US20040152737A1 (en) 2004-08-05
ZA200307955B (en) 2004-10-13
KR20040007544A (ko) 2004-01-24
HRP20030852A2 (en) 2005-06-30
WO2002089797A1 (en) 2002-11-14
CO5540378A2 (es) 2005-07-29
SK15002003A3 (sk) 2004-05-04
IL158413A0 (en) 2004-05-12
CA2446652A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20035156L (no) Fremgangsmåter for brønnbehandling
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
ATE381347T1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
DE60217317T8 (de) Wärmebehandlungsverfahren
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
DE60200578D1 (de) Ozonsterilisationsverfahren
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
NO20033804L (no) Karbamatforbindelser for behandling av smerte
NO20041968L (no) Anvendelse av cystationin
NO334788B2 (no) Fremgangsmåte for behandling av søvnløshet
NO20024236L (no) Behandling av psoriasis
SE0301854L (sv) Antiigensättningsbehandling
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
GB0124124D0 (en) Methods of treatment
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
NO20043113L (no) Fremgangsmate for behandling av benforstyrrelse
NO20034972L (no) Behandling av ADHD
ATE333439T1 (de) Pflanzenkläranlage
NO20030767L (no) Behandling av forbrenninger
NO20025765D0 (no) Kombinasjonssett for behandling av malaria
SE0104249D0 (sv) Method of treatment
NO20033160D0 (no) Anordning for behandling av gravann
NO20010171D0 (no) Teknisk behandling av tåke
DE60201822D1 (de) Sterilisierverfahren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application